Cited by 53Diabetes Management and ResearchDiabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Impact of Visit-to-Visit Fasting Plasma Glucose Variability on the Development of Type 2 Diabetes: A Nationwide Population-Based Cohort Study

Kim, Jung A., Lee, Ji Sung, Chung, Hye Soo, Roh, Eun, Lee, You-Bin, Hong, So-hyeon, Kim, Nam Hoon, Yoo, Hye Jin +5 more·2018·Diabetes Care

Abstract

OBJECTIVE: Although increasing evidence suggests the association between short-term variability of fasting plasma glucose (FPG) and diabetic complications or mortality, the impact of visit-to-visit variability of FPG on the development of type 2 diabetes (T2D) has not been evaluated. RESEARCH DESIGN AND METHODS: Our analysis included 131,744 Korean men and women without diabetes using the Korean National Health Insurance System cohort with periodic health examination program. FPG variability was calculated using the coefficient of variation (FPG-CV), SD (FPG-SD), and variability independent of the mean (FPG-VIM). RESULTS: During the median follow-up time of 8.3 years, Kaplan-Meier curves demonstrated lower disease-free probability in the higher FPG variability group compared with the lower FPG variability group. Multivariable Cox proportional hazards analysis exhibited that the hazard ratio for incident T2D was 1.67 (95% CI 1.58–1.77, P < 0.001) in the highest quartile of FPG-CV compared with the lowest quartile of FPG-CV after adjusting for confounding variables, including mean FPG. The association between FPG variability and the risk of T2D was consistent when modeling using FPG-SD and FPG-VIM in both normal and impaired fasting glucose groups. A 1 SD increase in the FPG-CV was associated with a 24% increased risk of T2D in the fully adjusted model. CONCLUSIONS: Increased variability of FPG is associated with the development of T2D independently of diverse risk factors.

Integrity signals

Registry

Crossref · 10.2337/dc18-0802

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Use of organization-approved protocols for insulin and other glucose-lowering medications can help reduce therapeutic inertia and/or reduce the risk of hypoglycemia and hyperglycemia.

    “Use of organization-approved protocols for insulin and other glucose-lowering medications can help reduce therapeutic inertia and/or reduce the risk of hypoglycemia and hyperglycemia (12,16 -18,262,263).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kim, J. A., Lee, J. S., Chung, H. S., Roh, E., Lee, Y.-B., Hong, S.-H., Kim, N. H., Yoo, H. J., Seo, J. A., Kim, S. G., Kim, N. H., Baik, S. H., & Choi, K. M.
Affiliations
  • Korea University (KR)
  • Asan Medical Center (KR)
Corresponding author
Choi, Kyung Mook
Venue
Diabetes Care
Published
2018-09-25
Volume
41
Issue
12
Pages
2610-2616
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2893574526
Cited by
52
References
30
Citations by year
2026: 1 · 2025: 2 · 2024: 7 · 2023: 7 · 2022: 8 · 2021: 9 · 2020: 11 · 2019: 6
FWCI
5.17
Type
journal article
Language
en
Open access
closed
Locations
  • Diabetes Care (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
type 2 diabetes, fasting blood glucose, glycemic variability, visit-to-visit variability, coefficient of variation, impaired fasting glucose, diabetes risk, Korean population
MeSH terms
Aged, Ambulatory Care, Blood Glucose, Diabetes Mellitus, Type 2, Fasting, Female, Follow-Up Studies, Humans, Male, Middle Aged, Prediabetic State, Risk Factors, Cohort Studies, Observer Variation, Disease Progression, Republic of Korea

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review